In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.

In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.

With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for a “unified approach” to strengthen Europe’s…